Research Article
Prognostic Significance of Blood, Serum, and Ascites Parameters in Patients with Malignant Peritoneal Mesothelioma or Peritoneal Carcinomatosis
Table 2
Survival analysis according to primary tumor type.
| Primary tumor | Patients number (%) | Median survival time months (range) |
| Mesothelioma | 43 (34.4) | 11 (1–42) | Ovary | 19 (15.2) | 9.5 (1–40) | Gastroenterology | 26 (20.8) | 7 (2–18) | Liver, gall, and pancreas | 24 (19.2) | 6 (1–25) | Other | 13 (10.4) | 6 (1–13) | Overall | 125 (100.0) | 8 (1–42) |
|
|